Insulin secretion from human beta cells is heterogeneous and dependent on cell-to-cell contacts
- First Online:
- Cite this article as:
- Wojtusciszyn, A., Armanet, M., Morel, P. et al. Diabetologia (2008) 51: 1843. doi:10.1007/s00125-008-1103-z
- 717 Views
We assessed the heterogeneity of insulin secretion from human isolated beta cells and its regulation by cell-to-cell contacts.
Insulin secretion from single and paired cells was assessed by a reverse haemolytic plaque assay. The percentage of plaque-forming cells, the mean plaque area and the total plaque development were evaluated after 1 h of stimulation with different secretagogues.
Not all beta cells were surrounded by a haemolytic plaque under all conditions tested. A small fraction of the beta cell population (20%) secreted more than 90% and 70% of total insulin at 2.2 and 22.2 mmol/l glucose, respectively. Plaque-forming cells, mean plaque area and total plaque development were increased at 12.2 and 22.2 compared with 2.2 mmol/l glucose. Insulin secretion of single beta cells was similar at 12.2 and 22.2 mmol/l glucose. Insulin secretion of beta cell pairs was increased compared with that of single beta cells and was higher at 22.2 than at 12.2 mmol/l glucose. Insulin secretion of beta cells in contact with alpha cells was also increased compared with single beta cells, but was similar at 22.2 compared with 12.2 mmol/l glucose. Delta and other non-beta cells did not increase insulin secretion of contacting beta cells compared with that of single beta cells. Differences in insulin secretion between 22.2 and 12.2 mmol/l glucose were observed in murine but not in human islets.
Human beta cells are highly heterogeneous in terms of insulin secretion so that a small fraction of beta cells contributes to the majority of insulin secreted. Homologous and heterologous intercellular contacts have a significant impact on insulin secretion and this could be related to the particular architecture of human islets.
KeywordsBeta cellsHeterogeneityHuman isletsInsulin secretionReverse haemolytic plaque assay
Connaught Medical Research Laboratory
- KRB 2.2
KRB Hepes buffer supplemented with 0.1% BSA and 2.2 mmol/l glucose
mean plaque area
plaque-forming cells or cell pairs
reverse haemolytic plaque assay
total plaque development
Endocrine cells are not randomly distributed within pancreatic islets. In most laboratory animals, islets consist of a core of insulin-secreting beta cells surrounded by alpha, delta and pancreatic polypeptide cells, which secrete glucagon, somatostatin and pancreatic polypeptide respectively . This complex architecture, which favours homologous cell-to-cell contacts, has been shown to be crucial for the normal function of the islet [2–5]. In animal models of diabetes, the well-defined islet architecture is disturbed [6, 7] so that glucagon- and somatostatin-containing cells are intermingled with beta cells. The same altered cellular organisation was reproduced in vitro by exposing islet cells to cytokines known to be secreted by leucocytes that infiltrate islets during diabetes onset .
The importance of homologous contacts between beta cells is further supported by the observation in rodents that the functioning of isolated beta cells is heterogeneous [9–13]. For instance, beta cells respond unequally to glucose stimulation in terms of insulin secretion and biosynthetic activity [12, 14, 15]. It has been suggested that intercellular contacts coordinate the functioning of beta cells by homogenising and synchronising their activities. This coordination is mediated at least in part by junctional structures and cell adhesion molecules. Specifically, beta cells are interconnected by gap junctions, which form channels across the extracellular space and allow direct exchanges of small cytoplasmic molecules, ensuring electrical coupling and promoting insulin secretion . Adhesion molecules such as integrins, cadherins and neural cell adhesion molecule have been described in islets and they somehow influence insulin secretion and are also involved in maintaining correct islet architecture [17–19].
The cytoarchitecture of human islets has been examined in detail only recently [5, 20]. Compared with animal models, the pattern of distribution of islet cells is unique in that the different endocrine cell types are distributed throughout the islet and not sorted into central and peripheral compartments. In addition, this structural dissimilitude has been associated with functional differences. Indeed, in contrast to mouse or rat islets, human islets displayed oscillations in intracellular calcium concentration that were not synchronised between beta cells. It has been suggested that this discontinuous activity of beta cells originates from the particular layout of beta cells in human islets .
Considering these above observations, we analysed whether heterogeneity in terms of insulin secretion also exists between human beta cells and how insulin secretion is affected by intercellular contacts. To this end, human islets isolated from different pancreases were dissociated and insulin secretion from single beta cells and aggregated cell pairs comprising beta and non-beta cells were studied by a reverse haemolytic plaque assay (RHPA) .
Human islets were isolated from human pancreases removed from brain-dead heart-beating donors. The use of human tissue for research was approved by our local institutional ethical committee, and our centre is a member of the European Consortium for Islet Transplantation for the islet research distribution programme, under the supervision of the Juvenile Diabetes Research Foundation. Islets were isolated and purified using Ricordi’s automated method  with local modifications . After isolation, islets were suspended in Connaught Medical Research Laboratory (CMRL) medium containing 5.6 mmol/l glucose and 10% FCS, and incubated for 24 h at 37°C and at 24°C thereafter.
Adult male DBA/1 mice were purchased from Janvier laboratories (Le Genest-Saint-Isle, France). All experimental protocols were reviewed and approved by the Institutional Animal Care and Use Committee, Department of Territory, State of Geneva. Mouse islets were isolated and purified using techniques previously described [17, 24]. Viability, as assessed by propidium iodide/fluorescein diacetate staining, was always higher than 80%. Isolated islets were then kept for 24 h and at 37°C in RPMI medium containing 10% FCS before static incubation tests were done.
Aliquots of 1,000 islet equivalents (IEQ; average islet diameter 150 μm) were rinsed twice with 10 ml PBS, resuspended in 1 ml Accutase (Innovative Cell Technologies, San Diego, CA, USA) and incubated at 37°C with gentle pipetting every 30 s. From 5 min onwards, complete cell dissociation was checked by microscopic observation of 10 μl aliquots sampled every min. When dissociation was considered to be complete (usually between 7 and 10 min), cells were diluted with 10 ml cold CMRL containing 10% FCS (vol./vol.). Before analysis by RHPA, cells were rinsed and incubated in this medium for either 1 to 2 h (in a first set of experiments) or for 24 h (in a second set of experiments) in order to increase cell-to-cell aggregation.
Insulin secretion by RHPA
Cunningham glass chambers (60 μl) were coated with 0.1 mg/ml poly-l-lysine (molecular mass 150,000–300,000; Sigma-Aldrich, Buchs, Switzerland). Islet cells were then rinsed with KRB Hepes buffer (125 mmol/l NaCl, 4.74 mmol/l KCl, 1 mmol/l CaCl2, 1.2 mmol/l KH2PO4, 1.2 mmol/l MgSO4, 5 mmol/l NaHCO3, 25 mmol/l HEPES, pH 7.4) supplemented with 0.1% BSA (wt/vol.) and 2.2 mmol/l glucose (KRB 2.2). Then, islets cells were diluted in KRB 2.2 to a density of 25 × 105 per ml and erythrocytes (sheep blood; Dade Behring, Servion, Switzerland) previously coated with Protein A (Amersham Bioscience, Dübendorf, Switzerland) were added to the cell suspension at a concentration of 5% (vol./vol.). This final preparation (60 μl) was introduced into a Cunningham chamber and placed in a damp box at 37°C. After 1 h, chambers were rinsed three times with 200 μl KRB 2.2, once with 200 μl testing buffer and once again with 100 μl testing buffer supplemented with a guinea pig polyclonal anti-insulin antibody prepared as described by Wright et al.  (dilution 1:300). Testing buffers were KRB 2.2 and KRB supplemented (1) with 12.2 mmol/l glucose, (2) with 22.2 mmol/l glucose, (3) with 2.2 mmol/l glucose + 25 mmol/l KCl, (4) with 22.2 mmol/l glucose + 25 mmol/l KCl and (5) with 22.2 mmol/l glucose + 25 mmol/l KCl + 0.5 mmol/l 3-isobutyl-1-methylxanthine (IBMX) + 100 nmol/l phorbol-12-myristate-13-acetate (PMA) + 10 µmol/l forskolin. After 1 h at 37°C, chambers were rinsed with KRB 2.2, then with this same buffer supplemented with guinea pig complement (dilution 1:40; Dade Behring). After 1 h at 37°C, chambers were rinsed with 0.04% Trypan Blue solution and incubated 5 min at room temperature, rinsed once with KRB 2.2 and finally filled with Bouin’s fixation solution.
To identify endocrine islet cells in RHPA, the Cunningham chambers were un-mounted and slides with fixed cells were rinsed in PBS, passed through a series of graded ethanols (30, 50, 70 and 90% [vol./vol.]), incubated for 15 min in PBS supplemented with 0.1% BSA and exposed for 1 h at room temperature to primary antibodies, diluted in PBS containing 0.1% BSA (wt/vol.). For simple staining, we used a guinea pig anti-insulin antibody (1:500 prepared as described by Wright et al. ); for double staining, we used this same antibody in combination with a mouse anti glucagon (1:400; Sigma) or a rabbit anti somatostatin antibody (1:3,000; Dako, Glostrup, Denmark). After rinsing with PBS, slides were incubated for 1 h at room temperature with secondary antibodies, diluted in PBS. For simple staining we used an FITC-conjugated goat anti-guinea pig antibody (1:400; Jackson ImmunoResearch Laboratories, West Grove, PA, USA); for double staining we used this same antibody in combination with a tetramethylrhodamine-conjugated donkey anti-mouse or a tetramethylrhodamine-conjugated donkey anti-rabbit antibody (1:200 and 1:900 respectively; Jackson ImmunoResearch Laboratories). After a last rinsing with PBS, slides were coverslipped with a solution of 0.02% of paraphenylenediamine in PBS–glycerol (1:2, vol./vol.) and sealed.
Slides were examined under a microscope (Zeiss Axiophot, Göttingen, Germany) with both phase-contrast and fluorescence illumination. Analysis was restricted to Trypan Blue-negative cells. Beta cells were identified by their fluorescent labelling. When simple staining was performed, single beta cells, beta cell pairs and pairs comprising one beta and one non-beta cell were analysed. Altogether, these cells represented 81 ± 13% (mean ± SD, n = 14) of the total beta cell population. Single beta cells represented 50 ± 13% (mean ± SD, n = 14) of the total beta cell population. When double staining was performed, single beta cells in direct contact with alpha and delta cells were analysed additionally. With phase-contrast illumination and using a calibrated grid eyepiece, diameters of haemolytic plaques formed around secreting single beta cells and cell pairs were measured. The percentage of plaque-forming cells or cell pairs (PFC) and the corresponding mean plaque area (MPA) were calculated. The total plaque development (TPD) reflecting the total amount of insulin secreted by 100 cells or cell pairs was calculated by multiplying the PFC by the MPA.
Mouse pancreases and human pancreas samples were fixed in 4% paraformaldehyde, then embedded in paraffin and sectioned. Sections were incubated for 15 min in PBS supplemented with 0.1% BSA and exposed for 2 h to an anti-glucagon antibody (1:100; Dako) and subsequently for 1 h to FITC-conjugated goat anti-rabbit antibody (1:500; Jackson ImmunoResearch).
Static incubation assay to assess insulin secretion from intact islets
Islets cultured for 24 h were rinsed three times with KRB 2.2 and aliquots of 50 IEQ were pre-incubated for 1 h in the same buffer at 37°C. Islets were then successively incubated for 1 h in KRB 2.2 (basal condition), then in KRB 12.2 or 22.2 mmol/l glucose (stimulated conditions) and once again in KRB 2.2 (re-basal condition). Incubation buffers were collected and frozen for further insulin measurements. After the last incubation, insulin was extracted from islets with acid-ethanol. Insulin was measured by ELISA using an ultra-sensitive human or mouse insulin detection kit (Mercodia, Uppsala, Sweden).
Data are expressed as means ± SEM. Statistica, version 6.0 software (Statsoft, Tulsa, OK, USA) was used for statistical analysis. Student’s t test and one-way ANOVA followed by least significant difference or Tukey’s post hoc tests were used for comparison of data. Values of p < 0.05 were considered as significant.
Insulin secretion of single human beta cell is heterogeneous
Insulin secretion from single human beta cells in response to glucose and other secretagogues
Heterogeneity of insulin secretion between donors does not correlate with donor, pancreas and islet cell characteristics
Insulin secretion from single beta cells evaluated per donor by RHPA after stimulation with 22.2 mmol/l glucose, with corresponding pancreas and beta cell characteristics
Cold ischaemia timeb (h)
Warm ischaemia timec (min)
Beta cell viabilityd (%)
Beta cell content (%)
Correlation with TPDe
Correlation with PFCe
Correlation with MPAe
The greatest proportion of insulin is secreted by a minority of beta cells
Differential secretory response to glucose between single and aggregated beta cells
Different secretory response to glucose in mouse compared with human islets
This study demonstrates that isolated human beta cells have heterogeneous insulin secretory activity and that cell-to-cell contact affects their insulin secretory activity.
Beta cell heterogeneity in terms of insulin secretion has been described in rodents [10, 21, 26] and is described here for the first time in humans. In rodents, beta cell heterogeneity was also observed in terms of metabolic, signalling [27, 28] and biosynthetic activities [12, 29]. Mechanisms explaining heterogeneity of beta cells are totally unknown. It cannot be completely ruled out that heterogeneity originates from different levels of beta cell viability in the experimental environment. However, more than 90% beta cells were Trypan Blue-negative and only these were analysed for insulin secretion. In addition, living cells were selected on the basis of the presence of a refringent border corresponding to an intact membrane. It is unlikely that heterogeneity could be related to apoptosis. Indeed, we know from other experiments performed under the same conditions (not shown) that less than 5% beta cells were TUNEL-positive. After maximal stimulation with a mixture of secretagogues comprising glucose, KCl, IBMX, PMA and forskolin, the number of non-secreting beta cells was largely decreased as compared with glucose stimulation. This indicates that most non-secreting cells under glucose stimulation were not damaged, but may need to be stimulated with a secretagogue other than glucose in order to secrete insulin. Whether heterogeneous insulin secretion results from differential cellular insulin contents is unknown and difficult to investigate. Using immunofluorescence, we showed that virtually all beta cells were strongly labelled for insulin and consequently were not degranulated. This indicates that degranulation does not account for the heterogeneity we observed in insulin secretion. New technologies will be required to explore whether more subtle differences in cellular insulin content could have an effect on insulin secretion.
Even though heterogeneity of insulin secretion was observed in all cell preparations, PFC, MPA and consequently TPD varied considerably between cell preparations. We assessed correlations between RHPA data and donor, pancreas and islet cell characteristics. Characteristics that varied highly between donors were age, BMI and glycaemia. None of these characteristics correlated with RHPA data. Cold and warm ischaemia times are critical pancreas variables that could affect insulin secretion. However, no correlation was observed between ischaemia times and RHPA data. At the cellular level, we analysed viability, beta cell content and percentage of aggregated cells; again no correlation was observed with RHPA data. It remains to be investigated whether other cell characteristics, involving glucose metabolism, cell signalling or insulin biosynthesis, are related to insulin secretion outcome of beta cells.
Studying the repartition of secreting cells in relation to plaque areas, we noticed that the majority of insulin was secreted by very few beta cells. In fact, only 20% of the total beta cell population secreted more than 90% and 70% of the total amount of insulin released at low and high glucose concentration, respectively. There is no evidence in our data that this pattern of secretion exists in whole islets. In rats, heterogeneous secretion of islet beta cells has been demonstrated in vivo by systemic perfusion of glucose and glibenclamide . Of course, this kind of experiment is impossible in humans. Based on several reports on the ‘pacemaker’ activity of islet cells , we speculate that the cells secreting at high levels could act as ‘leader’ cells that trigger insulin secretion from all beta cells within the same islet. This could occur by cell synchronisation via calcium influx through gap junctions [32, 33], via metabolic  or by other extracellular signals [34, 35].
As expected from previous rodent studies [26, 30], homologous contacts between human beta cells potentiated insulin secretion. In addition, and for the first time, we showed that a single intercellular contact between an alpha cell and a beta cell was able to increase insulin secretion. This effect could be explained by a paracrine action of glucagon, meaning that the quantity of glucagon secreted by a single alpha cell, even at high glucose concentration, is sufficient to affect secretion of beta cells. Similar paracrine mechanisms could account for the observed effect of delta cells on insulin secretion. Our results are also consistent with Pipeleers et al. , who demonstrated potentiation of first and second insulin secretion phases in coupled rat beta cells and reported that a fraction of beta cells enriched with alpha cells had a secretory response comparable to coupled beta cells . Beside this paracrine hypothesis, it is conceivable that adhesion and junctional molecules also play a role in the effect of homologous and heterologous intercellular contacts on insulin secretion. Previous work with rat beta cells has shown that intercellular coupling through gap junctions is involved in glucose-regulated insulin secretion . Whether gap junctions or other types of intercellular contact are involved in insulin secretion of human beta cells remains to be investigated.
Intriguingly, insulin secretion in single beta cells was similar at 12.2 and 22.2 mmol/l, a pattern which, just as interestingly, was not found in beta cell pairs. Indeed, when homologous contacts between beta cells were established (as in beta cell pairs), insulin secretion was higher at 22.2 than at 12.2 mmol/l glucose. Therefore these results indicate that homologous contacts between beta cells somehow improve regulated insulin secretion, facilitating insulin secretion when required by extreme metabolic needs. We propose that in human islets, homologous beta cell contacts are reduced by the high number of non-beta cells that are intermingled with beta cells. Consequently in human islets no significant difference could be observed between 22.2 and 12.2 mmol/l glucose. We propose that total insulin secretion from human islets arises from beta cells that are differently regulated according to their neighbouring cells. At moderate glucose concentrations (up to 12.2 mmol/l), insulin secretion from beta cells is potentiated by beta–beta and beta–alpha contacts and not affected or possibly decreased by interactions with other islet cell types. At higher glucose concentrations (22.2 mmol/l), only beta–beta contacts may be able to further potentiate insulin secretion. In rodent islets, homologous contacts between beta cells are predominant and consequently a significant difference is observed in insulin secretion between 22.2 and 12.2 mmol/l glucose.
Differences between species in islet architecture have been described extensively elsewhere . The implications of these findings in islet function have been mentioned in terms of human beta cell de-synchronisation within islets and high sensitivity of human islets to low glucose concentrations . From those findings and our paired cell experiments, it seems that mostly paired cells in the core of mouse islets have a high sensitivity to glucose but poor control in case of rapid variations in the low-glucose state , whereas human islets have a more complex system of regulation with both cell-to-cell inhibition/activation of insulin secretion, higher glucagon content and better control in the low-glucose state.
Taken together, our results demonstrate that individual human beta cells are highly heterogeneous with regard to their secretory activity and that both homologous and heterologous intercellular contacts affect regulation of their insulin secretion. We therefore propose that the particular cytoarchitecture of human islets with abundant heterologous cell-to-cell interactions may have a functional relevance in the optimal regulation of insulin secretion.
We thank D. Matthey-Doret for his excellent technical assistance. This work was supported by grant 3200B0-116562 from the Swiss National Science Foundation (to P. Morel, T. Berney and D. Boso). Human islets were provided through JDRF award 6-2005-1178.
Duality of interest
The authors declare that there is no duality of interest associated with this manuscript